Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies

Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies

Cardiovascular outcome trials (CVOT) showed that treatment with glucagon-like peptide-1 receptor agonists (GLP-1RA) is associated with significant cardiovascular benefits. However, CVOT are scarcely representative of everyday clinical practice, and real-world studies could provide clinicians with mo...

Full description

Bibliographic Details
Main Authors:	Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Metabolites
Subjects:	type 2 diabetes cardiovascular disease renal disease kidney MACE real-world evidence
Online Access:	https://www.mdpi.com/2218-1989/12/2/183

Similar Items

Incretin-based therapies for the treatment of obesity-related diseases
by: Irene Caruso, et al.
Published: (2024-11-01)

Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysisResearch in context
by: Irene Caruso, et al.
Published: (2023-10-01)

Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity
by: Nicola Marrano, et al.
Published: (2021-02-01)

Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
by: Anna Leonardini, et al.
Published: (2009-01-01)

Effects of Extra Virgin Olive Oil Polyphenols on Beta-Cell Function and Survival
by: Nicola Marrano, et al.
Published: (2021-02-01)

Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis
by: Gabriella Garruti, et al.
Published: (2023-05-01)

The triglyceride-glucose index is a predictor of major adverse cardiovascular events in patients with coronary artery disease and psoriasis: a retrospective cohort study
by: Bingqi Fu, et al.
Published: (2024-07-01)

Major Adverse Cardiovascular Events Following Coronary Artery Stenting by History of Hypertensive Disorder of Pregnancy
by: Omar Sigurvin Gunnarsson, et al.
Published: (2024-10-01)

Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
by: Nicola Marrano, et al.
Published: (2023-01-01)

Confounding factors responsible for elevated Lp(a) levels in patients with coronary artery disease
by: Navaneeth Amin, et al.
Published: (2024-01-01)

lncRNA TPRG1-AS1 Screened the Onset of Acute Coronary Syndromes and Predicted Severity and the Occurrence of MACE During Patients’ Hospitalization
by: Zhang F, et al.
Published: (2023-11-01)

Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease
by: Nikolaos P. E. Kadoglou, et al.
Published: (2022-09-01)

GLP-1 Receptor Agonists and Kidney Protection
by: Eulalia Valentina Greco, et al.
Published: (2019-05-01)

Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study
by: Marta Baviera, et al.
Published: (2022-08-01)

GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes
by: Raffaele Marfella, et al.
Published: (2024-01-01)

Gender inequalities in secondary prevention of cardiovascular disease: a scoping review
by: Irene López Ferreruela, et al.
Published: (2024-07-01)

Technological Advances Are Associated With Better Clinical Outcomes of Percutaneous Coronary Intervention in Patients With Unprotected Left Main Disease
by: Dong Zhang, et al.
Published: (2024-08-01)

Perioperative cardiovascular outcome in patients with coronary artery disease undergoing major vascular surgery: A retrospective cohort study
by: Diana Thomas, et al.
Published: (2022-01-01)

Role of Osteopontin in Predicting Short-Term Major Adverse Cardiac Events and Infarction Size in STEMI
by: Soliman Belal, et al.
Published: (2021-08-01)

Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
by: Mehmet Yildiz, et al.
Published: (2023-06-01)

Using troponin I to predict MACE after CABG
by: Siti Elkana Nauli, et al.
Published: (2013-06-01)

Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized
by: Stephen J Wood, et al.
Published: (2022-07-01)

SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain
by: Bartosz Rolek, et al.
Published: (2023-07-01)

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
by: Giulia Monti, et al.
Published: (2022-06-01)

Vitiligo is associated with an increased risk of cardiovascular diseases: a large-scale, propensity-matched, US-based retrospective studyResearch in context
by: Alicja Frączek, et al.
Published: (2024-11-01)

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease
by: Xiao Zou, et al.
Published: (2023-06-01)

Effects of Metabolic Syndrome on Cardiovascular Outcomes of Psoriatic Patients with Coronary Artery Disease: A Single Center Retrospective Cohort Study
by: Zhao L, et al.
Published: (2023-04-01)

Correlation between serum laminin levels and prognosis of acute myocardial infarction
by: Lou-Yuan Xu, et al.
Published: (2022-07-01)

The effect of ivabradine on long term prevention of major adverse cardiac events in acute coronary syndrome using high-sensitivity C-reactive protein level
by: Ahmed Fouad AbdEl Latif, et al.
Published: (2015-08-01)

Piezoresistance Characterization of Silicon Nanowires in Uniaxial and Isostatic Pressure Variation
by: Elham Fakhri, et al.
Published: (2022-08-01)

IL-6, IL-1RA and Resistin as Predictors of Left Ventricular Remodelling and Major Adverse Cardiac Events in Patients with Acute ST Elevation Myocardial Infarction
by: Alina Ioana Scărlătescu, et al.
Published: (2022-01-01)

ORIGINAL PAPER<br> Preprocedural fibrinogen levels and MACE after percutaneous coronary intervention
by: Leszek Markuszewski, et al.
Published: (2006-03-01)

Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis
by: Alhassane Diallo, et al.
Published: (2022-12-01)

GLP-1 receptor agonist as a modulator of innate immunity
by: Jun Chen, et al.
Published: (2022-12-01)

Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
by: Tomislav Bulum
Published: (2022-10-01)

Associations Among Depression, Hemoglobin A1c Level, and Prognosis in Patients With Coronary Artery Disease: A Prospective Study
by: Weiya Li, et al.
Published: (2022-06-01)

The Prognostic Value of Thyroid-Stimulating Hormone in Patients with Coronary Artery Disease and Depression
by: Li W, et al.
Published: (2022-05-01)

Risk stratification using the CHA2DS2-VASc score in patients with coronary heart disease undergoing percutaneous coronary intervention; sub-analysis of SHINANO registry
by: Hirofumi Hioki, et al.
Published: (2015-06-01)

Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence
by: Meir Schechter, et al.
Published: (2023-05-01)

GLP-1 receptor agonists—another promising therapy for Alport syndrome?
by: Jan Boeckhaus, et al.
Published: (2025-03-01)